American Academy of Neurology (AAN)
- Guideline on diagnosis and treatment of Guillain–Barré syndrome (2023)
- Oral and topical treatment of painful diabetic polyneuropathy practice guidelines (2021)
- American Academy of Pain Medicine (AAPM)Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition (2022)
American Diabetes Association
- Diabetic neuropathy: a position statement by the American Diabetes Association (2016)Canadian Pain Society
- Evidence-based guideline for neuropathic pain interventional treatments: spinal cord stimulation, intravenous infusions, epidural injections and nerve blocks (2012)
Centers for Disease Control and Prevention (CDC)
European Federation of Neurological Societies (EFNS)/Peripheral Nerve Society (PNS)
- Guideline on diagnosis and treatment of Guillain–Barré syndrome (2023)
- Guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision. (2021)Guideline on management of multifocal motor neuropathy (2010)
- Guideline on management of paraproteinemic demyelinating neuropathies (2010)
Infectious Diseases Society of America (IDSA)/HIV Medicine Association (HIVMA)
International Association for the Study of Pain Neuropathic Pain Special Interest Group (NeuPSIG)
National Institute for Health and Care Excellence (NICE)
Toronto Expert Panel on Diabetic Neuropathy
U.S. Department of Health & Human Services
Veterans Affairs/Department of Defense (VA/DoD)
Reviewer 1: Claire Herbst, PharmD, BCPS, BCPP
Reviewer 2: Danielle Dauchot, PharmD, BCPP
2025-2026 AAPP Resident and New Practitioner Committee